H/t reader kevin a.
* * *
By Dr. Mercola
Direct-to-consumer (DTC) drug advertising, which began in 1997, has done a lot more than make Pharma arguably the most profitable industry in the world and a Wall Street success story. It has greatly increased the number of prescription drugs that Americans take. In 1992, five years before DTC advertising began, Americans took an average of seven prescription drugs a year. A mere 15 years later that number had nearly doubled to 12 per year.1,2
To sell drugs, aggressive drug advertising whips up fears over rare diseases like exocrine pancreatic insufficiency (introduced at the 2017 Super Bowl) and make a disease out of common, nearly universal conditions to frighten and motivate people into taking prescription drugs.
Another DTC advertising tactic is convincing people to take drugs simply because they might be “at risk” of a condition. Sadly, drug advertising is not the only way Pharma gets dangerous drugs into the nation’s medicine chests. Thanks to outrageous conflicts of interest at the U.S. Food and Drug Administration (FDA) — the new FDA Commissioner, Dr. Scott Gottlieb, is a drug company consultant — drugs that would once have not been approved fly through their approvals.
Personally, I would never ever take (deadly) drugs like Xarelto.
By Dr. Mercola
If you have noticed that prescription drugs are becoming more dangerous — and more expensive — you are right. As the drug industry’s influence over the U.S. Food and Drug Administration (FDA) increases, dangerous drugs are approved and marketed despite their clear risks to patients.
Recent examples include the aggressively promoted blood thinners Xarelto and Pradaxa which cause uncontrollable bleeding, the testosterone drug Androgel, for “Low T” linked to noncalcified plaque buildup in coronary arteries, and fluoroquinolone antibiotics. When warnings are added to these dangerous drugs or they are withdrawn, like 28 popular drugs have been, many wonder why media failed to report the safety risks while they were occurring.1
START – Theresa May to focus on Brexit transition agreement
02:11 – Mogherini’s EU military: a global security provider…
07:54 – RAF has a new Qatari wing: meet 12 squadron
09:28 – Behavioural change in the NHS: a force for good or not…?
UK Column analysis with Dr Graham Downing
26:53 – BBC uses RIPA terrorism laws to catch TV licence fee “dodgers”
30:53 – Child sexual abuse: Shatterboys UK revisited
37:50 – Scottish economy growth estimates below 1% until 2022…
39:31 – BBC fake news: Russia – a ‘new risk’ to undersea cables…
H/t reader squodgy:
We reallt do have a serious problem with the BigPharma bulldozer.”
* * *
by Jon Rappoport
December 13, 2017
The old question about a tree falling in the forest is relevant here. Does the tree make a sound if no one is there to hear it?
If a scandal erupts and the press doesn’t cover it, is it a scandal?
If this sounds strange, consider that, since the dawn of time, whatever has passed for mainstream news has substituted for the direct observation of events by humans. The press has functioned as the eyes and ears and even mouths of the public.
One out of every three American adults take statins, and if you think that sounds like good news for statin manufacturers, you’re missing the bigger picture. All of Big Pharma benefits when people take statins. In fact, statins can really be thought of as gateway drugs. After all, they have so many side effects that you will likely end up taking several other medications after you start statins just to deal with them.
What can happen to you if you take these dangerous drugs? They suppress your body’s immune system, rendering it less able to fight off infections. They also inhibit production of coenzyme Q10, which helps to regulate your immune and nervous system and maintain a healthy heart and blood pressure. There’s also a higher risk of neurological diseases when you take statins, with many patients reporting forgetfulness, confusion and memory loss. But don’t worry – whatever happens to you, Big Pharma has a solution for that, too!
The Drug Enforcement Agency (DEA) is now free to ban all access to a plant known as kratom (Mitragyna speciosa) that for centuries has served as a natural remedy for pain, and that’s helped countless opiate addicts overcome withdrawal symptoms. The federal government claims that kratom serves no legitimate medical purpose, but a closer look reveals that not only is the opposite true, but drug companies actually hold patents on kratom’s medicinal compounds. Public uproar after the DEA announced its plans has led to the agency saying in statements that it has no “timetable for officially listing kratom—it could be next week or longer—leaving users on the edge of their seats,” according to ARS Technica.
The DEA plans to classify kratom as a “Schedule I” drug – the highest classification reserved for hard drugs like heroin – and claims that kratom has a high potential for abuse and serves no legitimate purpose in health. However, several patents, including one dating back to 1964, show that kratom’s alkaloid compounds indeed exhibit pharmacodynamic activity.
Three compounds in particular – MGM-9, MGM-15, and MGM-16 – serve as proof that kratom holds therapeutic potential. Each of these synthetic opioid compounds was synthesized from various alkaloids present in the kratom plant; MGM-9 came from a compound known as mitragynine, while MGM-15 and MGM-16 came from 7-hydroxymitragynine. These two compounds are considered to be among the primary active constituents in kratom.
By Dr. Mercola
The U.S. has a massive opioid addiction problem. According to the U.S. surgeon general, more Americans now use prescription opioids than smoke cigarettes,1 and addiction to narcotic pain relievers now costs the U.S. more than $193 billion each year. The Manchester, New Hampshire, fire department recently said it now responds to more calls for drug overdoses than fires.2 That’s not so surprising when you consider that opioids are now the leading cause of death among Americans under the age of 50.3
You’re aware America is under siege, fighting an opioid crisis that has exploded into a public-health emergency. You’ve heard of OxyContin, the pain medication to which countless patients have become addicted. But do you know that the company that makes Oxy and reaps the billions of dollars in profits it generates is owned by one family?
The newly installed Sackler Courtyard at London’s Victoria and Albert Museum is one of the most glittering places in the developed world. Eleven thousand white porcelain tiles, inlaid like a shattered backgammon board, cover a surface the size of six tennis courts. According to the V&A’s director, the regal setting is intended to serve as a “living room for London,” by which he presumably means a living room for Kensington, the museum’s neighborhood, which is among the world’s wealthiest. In late June, Kate Middleton, the Duchess of Cambridge, was summoned to consecrate the courtyard, said to be the earth’s first outdoor space made of porcelain; stepping onto the ceramic expanse, she silently mouthed, “Wow.”
If you’ve ever been to a famous art museum or glanced around a prestigious university, you’ve probably seen a wing or building named after a member of the Sackler family. But many may not know that the family’s fortune comes from selling pharmaceuticals—most notably OxyContin, the addictive painkiller at the center of America’s opioid epidemic.
A new profile in Esquire chronicles the life and business practices of Arthur, Mortimer and Raymond Sackler, three brothers from a Jewish immigrant family who built a medical empire. Their descendants privately own Purdue Pharma, which was instrumental in using lobbying and advanced marketing techniques to convince doctors of the need to manage patients’ pain—and then prescribe OxyContin to manage it.
30 million Americans who woke perfectly healthy yesterday morning are now suddenly in need of expensive hypertension treatments after the American Heart Association and the American College of Cardiology decided to lower the definition of “high blood pressure” to 130/80 from the previous trigger of 140/90. According to Reuters, the change means that nearly 50% of American adults, or roughly 100 million people, now suffer from high blood pressure.
(NaturalNews) One of the world’s most lucrative industries, spending on cancer drugs reached an all-time high last year, as it was valued at more than $100 billion. Spending on cancer drugs increased 6.5 percent annually over the past five years and is expected to continue growing at a rate of 8 percent each year through 2018, according to figures provided by the IMS Institute for Healthcare Informatics.
That spending is highly concentrated, as the US and five of Europe’s largest countries account for nearly two-thirds of the entire market.
This means that billions and billions of dollars are secured by Americans being diagnosed with cancer.
That’s one profitable industry; however, it could all be completely dismantled by one thing: a cure.
His comments have fuelled the debate surrounding the group of medicines, the most widely prescribed treatment in the UK given to up to 12 million patients, or around one in four adults.
Use of the drugs fiercely divides medical opinion with proponents arguing the benefits in reducing the risk of heart attacks and stroke far outweigh the risk of side effects which include severe muscle pain, impotence, cataracts, mental impairment, diabetes, fatigue and liver dysfunction.
H/t reader kevin a.
* * *
How would you feel if a beloved family member died because of the greed of a pharmaceutical company that knowingly continued marketing a deadly drug for 30 years after they found out it could kill people? That is the position of the families of nearly 2,300 French patients who died after using the drug benfluorex – marketed in France under the name Mediator – to treat diabetes. The drug’s history is shrouded in a veil of corruption and cover-ups, but the French government is now pursuing pharma giant Servier to the full extent of the law.
The British Medical Journal (BMJ) is reporting that criminal charges have been laid against Servier itself, French regulatory bodies that looked the other way while Mediator continued to kill people, companies affiliated to Servier, and 14 individuals directly involved in the fraud.
University of Sydney study finds Australian nurses attended thousands of drug industry sponsored events amid concerns they can lead to healthcare professionals being influenced to use particular medical devices or drugs
H/t reader kevin a.